Corixa Antigens definition

Corixa Antigens means (i) those Antigens identified on Exhibit A attached hereto and/or (ii) those Antigens solely discovered by Corixa during the Research Program Term as may be extended in connection with and as a result of the Research Program and/or (iii) those Antigens discovered by Corixa as a result of research directed to PC during the Research Program Term as may be extended but not in connection with and not as a result of the Research Program and, subject to SB's exercize of the option set forth in Paragraph 4(d) below, during a period of two (2) years after the Research Program Term as may be extended and/or (iv) subject to SB's compliance with the terms and conditions of Paragraph 4(c) below, those Antigens in the PC Field licensed-in or otherwise acquired by Corixa during the Research Program Term as may be extended and, subject to Paragraph 4(d) below, during a period of two (2) years thereafter. As used herein, Corixa Antigens shall not include Research Program Antigens nor SB Antigens.
Corixa Antigens means (i) those Antigens identified on Exhibit A attached hereto and/or (ii) those Antigens solely discovered by Corixa during the Research Program Term as may be extended in connection with and as a result of the Research Program and/or (iii) those Antigens discovered by Corixa as a result of research directed to PC during the Research Program Term as may be extended but not in connection with and not as a result of the Research Program and, subject to SB's exercize of the option set forth in Paragraph 4(d) below, during a period of [***] after the Research Program Term as may be extended and/or (iv) subject to SB's compliance with the terms and conditions of Paragraph 4(c) below, those Antigens in the PC Field licensed-in or otherwise acquired by Corixa during the Research Program Term as may be extended and, subject to Paragraph 4(d) below, during a period of [***] thereafter. As used herein, Corixa Antigens shall not include Research Program Antigens nor SB Antigens.
Corixa Antigens means Existing Corixa Antigens and New Corixa Antigens. As used herein, Corixa Antigens shall not include R&D Program Antigens or SB Antigens.

Examples of Corixa Antigens in a sentence

  • For purpose of clarity, the foregoing license shall include rights of SB to Corixa Antigens and/or Research Program Antigens in and outside the PC Field but in the Licensed Field; any commercial use of such Corixa Antigens and/or Research Program Antigens shall be subject to the royalties set forth in Section 6 in the same manner as royalties are paid on Products thereunder.

  • For purpose of clarity, the foregoing license shall include rights of SB to Corixa Antigens and/or Research Program Antigens in and outside the BC Field but in the Licensed Field; any commercial use of such Corixa Antigens and/or Research Program Antigens shall be subject to the royalties set forth in Section 6 in the same manner as royalties are paid on Products thereunder.

  • With respect to all licenses granted by Corixa hereunder to Third Parties as allowed under the terms and conditions of Sections 5(d) and 5(g)(iii) for the use of Corixa Antigen(s) and/or R&D Program Antigen(s) in Diagnostic products, Corixa shall pay to SB [***] provided, however, that Corixa shall have no such payment obligation in connection with [***].

  • Subject to all of the terms of this Agreement, during the R&D Program Term as may be extended and any Intended Clinical Delay, Corixa shall granx XX x xight of first refusal with respect to all Diagnostics (other than TDM Products) comprised of at least one (1) Corixa Antigen(s) and/or R&D Program Antigen(s), excluding those Diagnostics that Corixa has [***].


More Definitions of Corixa Antigens

Corixa Antigens means the antigens listed in Exhibit A hereto.

Related to Corixa Antigens

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Licensed Compound means [***].

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Antigen means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • GSK has the meaning set forth in the preamble.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Merck has the meaning set forth in the preamble.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Biological Materials means certain tangible biological materials that are necessary for the effective exercise of the Patent Rights, which materials are described on Exhibit A, as well as tangible materials that are routinely produced through use of the original materials, including, for example, any progeny derived from a cell line, monoclonal antibodies produced by hybridoma cells, DNA or RNA replicated from isolated DNA or RNA, recombinant proteins produced through use of isolated DNA or RNA, and substances routinely purified from a source material included in the original materials (such as recombinant proteins isolated from a cell extract or supernatant by non-proprietary affinity purification methods). These Biological Materials shall be listed on Exhibit A, which will be periodically amended to include any additional Biological Materials that Medical School may furnish to Company.

  • Non-Microsoft Product means any third-party-branded software, data, service, website or product, unless incorporated by Microsoft in a Product.

  • Collaboration Know-How means all Know-How and Materials discovered, created, conceived, developed or reduced to practice in the course of performing activities under the Collaboration Program (whether solely by one Party or jointly by the Parties, in each case with their Affiliates or any Third Parties or any employees, consultants or agents of any of the foregoing which perform activities under the Collaboration Program).

  • Research Program has the meaning set forth in Section 2.1.

  • Manufacturing Technology means any and all patents, patent applications, Know-How, and all intellectual property rights associated therewith, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno- associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • ISIS means the department’s individualized services information system.

  • Novartis shall have the meaning set forth in the Preamble.

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.